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ABSTRACT Antiviral innate host defenses against acute viral infections include sup-
pression of host protein synthesis to restrict viral protein production. Less is known
about mechanisms by which viral pathogens subvert host antiviral innate responses
for establishing their replication and dissemination. We investigated early innate de-
fense against human immunodeficiency virus (HIV) infection and viral evasion by uti-
lizing human CD4 T cell cultures in vitro and a simian immunodeficiency virus (SIV)
model of AIDS in vivo. Our data showed that early host innate defense against the
viral infection involves GCN2-ATF4 signaling-mediated suppression of global protein
synthesis, which is exploited by the virus for supporting its own replication during
early viral infection and dissemination in the gut mucosa. Suppression of protein
synthesis and induction of protein kinase GCN2-ATF4 signaling were detected in the
gut during acute SIV infection. These changes diminished during chronic viral infec-
tion. HIV replication induced by serum deprivation in CD4 T cells was linked to the
induction of ATF4 that was recruited to the HIV long terminal repeat (LTR) to pro-
mote viral transcription. Experimental inhibition of GCN2-ATF4 signaling either by a
specific inhibitor or by amino acid supplementation suppressed the induction of HIV
expression. Enhancing ATF4 expression through selenium administration resulted in
reactivation of latent HIV in vitro as well as ex vivo in the primary CD4 T cells iso-
lated from patients receiving suppressive antiretroviral therapy (ART). In summary,
HIV/SIV exploits the early host antiviral response through GCN2-ATF4 signaling by
utilizing ATF4 for activating the viral LTR transcription to establish initial viral replica-
tion and is a potential target for HIV prevention and therapy.
IMPORTANCE Understanding how HIV overcomes host antiviral innate defense re-
sponse in order to establish infection and dissemination is critical for developing
prevention and treatment strategies. Most investigations focused on the viral patho-
genic mechanisms leading to immune dysfunction following robust viral infection
and dissemination. Less is known about mechanisms that enable HIV to establish its
presence despite rapid onset of host antiviral innate response. Our novel findings
provide insights into the viral strategy that hijacks the host innate response of the
suppression of protein biosynthesis to restrict the virus production. The virus lever-
ages transcription factor ATF4 expression during the GCN2-ATF4 signaling response
and utilizes it to activate viral transcription through the LTR to support viral tran-
scription and production in both HIV and SIV infections. This unique viral strategy is
exploiting the innate response and is distinct from the mechanisms of immune dys-
function after the critical mass of viral loads is generated.
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Acute viral infections trigger an antiviral host innate defense response in theinfected host for restricting viral replication and dissemination (1). However, viral
pathogens have evolved mechanisms either to overcome host antiviral mechanisms
or to exploit them for supporting viral replication. Human immunodeficiency virus
type 1 (HIV) establishes persistent infection in humans and is the cause of the AIDS
epidemic worldwide (2). Gut-associated lymphoid tissue is an early target organ for
the establishment of HIV infection and dissemination and a site for viral persistence
(3). The impact of established chronic HIV infection in therapy-naive individuals is
well documented by the incidence of gastrointestinal complications, including
nutrient malabsorption, impaired immunity, and metabolic dysfunction. The role of
infectious virus and viral antigens in the pathogenesis of immune dysfunction in
HIV infection has been well investigated (4–7). However, our understanding of the
early host-virus interactions at the mucosal sites is limited. During the initial
encounter with the susceptible host cell targets, HIV infection triggers a signaling
cascade that induces multiple innate antiviral defenses and primes the host for
generating virus-specific immune responses (8). Mechanisms by which HIV lever-
ages some of the host innate defenses for its own benefit are not fully explored.
This feature is especially critical for the virus to invade and establish infection in the
gut mucosa since the gastrointestinal tract is immunologically highly evolved to
combat the incoming pathogens and is richly endowed with innate immune
defenses (9). We propose that the virus might utilize the early antiviral host innate
response for supporting its own transcription/replication and to build a critical mass
of viral loads at the site of infection. This step is critical for advancing viral
dissemination to other susceptible targets and for impairing host immunity.
HIV is greatly dependent on the host cell protein synthetic machinery for producing
viral proteins and infectious viral particles. It has been well established that acute viral
infections activate an antiviral response in host cells that includes inhibition of protein
synthesis and amino acid deprivation (10). This leads to the restriction of the viral
protein production and results in the control of the viral infection through the mech-
anism of phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2). HIV
infection of cell lines in vitro induced inhibition of protein translation and increased
expression of the protein kinase general control nonderepressible 2 (GCN2) (10).
Phosphorylation of eIF2 by activated GCN2 converts eIF2 to a competitive inhibitor of
eIF2B and results in the inhibition of protein synthesis (11). Despite the suppression of
global protein synthesis during viral infections, a specific set of mRNAs is preferentially
translated, including the transcription factor ATF4 (12). It is not known whether ATF4
expression is altered during early stages of HIV/simian immunodeficiency virus (SIV)
infections and whether it activates HIV transcription. Therefore, we sought to investi-
gate the host antiviral response integrating GCN2 activation and amino acid deficiency-
driven ATF4 expression to understand whether the virus would exploit these mecha-
nisms for enhancing its own replication and expansion. The SIV model of AIDS has been
valuable for unraveling the mechanisms of HIV pathogenesis. A combination of the SIV
model and well-established HIV cell culture systems in vitro provides an excellent
opportunity to interrogate early stages of viral infection in the context of host antiviral
innate defense and mechanisms of viral evasion or exploitation of the host antiviral
pathways for establishing early viral reservoirs (10, 13–16).
In this study, our data show rapid suppression of protein biosynthesis and amino
acid metabolism in the gut mucosa of rhesus macaques during very early stages of SIV
infection in vivo (within 60 h of infection). This effect was linked to activation of
GCN2-ATF4 signaling in the gut mucosa. These data were validated by the induction of
ATF4 gene expression in primary human CD4 T cells following direct HIV infection ex
vivo. Experimentally induced amino acid deficiency in CD4 T cell cultures in vitro
resulted in the induction of ATF4 expression, which supported increased HIV transcrip-
tion. ATF4 binding to the HIV long terminal repeat (LTR) was detected during amino
acid deficiency. In the CD4 T cells under nutrient insufficiency conditions, addition of
GCN2-specific inhibitor or supplementation of amino acids to the cells resulted in the
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suppression of HIV reactivation. We propose that the viral infection-induced host
response of amino acid deficiency induces ATF4 expression. ATF4 in turn binds to
the viral promoter in the LTR region and promotes HIV replication. Our findings
suggest that while GCN2-ATF4 signaling is activated as a host antiviral innate
defense to limit viral protein translation and infection, HIV/SIV is able to hijack
GCN2-ATF4 signaling for its own replication and establishment of infection. The HIV
infection-induced ATF4 signaling pathway could be targeted as a new strategy to
confront latent HIV infection.
RESULTS
In vivo metabolic changes in the gut mucosa during early SIV infection. To
determine the early host antiviral response to SIV infection, intestinal tissue and
peripheral blood samples were obtained from rhesus macaques at 60 h (early stage of
infection) and 10 weeks (chronic stage of viral infection) following SIV infection.
Progression of infection was monitored by the measurement of viral loads and CD4
T cell numbers (Table 1). Effects of the viral infection on the host were examined
through metabolic analysis. During early SIV infection, plasma viral loads ranged from
301 to 1,106 SIV RNA copies/ml while the gut tissue viral loads ranged from 86 to 562
SIV copies/g total RNA (n 3). No detectable loss of CD4 T cells was observed in the
peripheral blood and intestine of animals at 60 h following SIV infection (17). The CD4
T cell numbers in peripheral blood were similar to preinfection values (average,
1,002 cells/l), while CD4 T cell percentages in the gut ranged between 41 and 53%
and were similar to those of uninfected controls (n 4). In contrast, loss of CD4 T cells
in both peripheral blood and gut mucosa was detected during chronic SIV infection.
Plasma viral loads ranged from 2.3  104 to 2.4  105 RNA copies/ml, while viral loads
in intestinal tissue ranged from 5.7  103 to 2.4  105 SIV copies/g total RNA (again,
n  4). The CD4 T cell numbers in the peripheral blood ranged from 217 to
1,178 cells/l (605  407 cells/l) at 10 weeks post-SIV infection compared to prein-
fection values of 1,009 to 1,792 cells/ml (1,269  355 cells/l), while CD4 T cell
percentages in the gut were substantially lower than in the controls, suggesting the
occurrence of CD4 T cell loss that is the hallmark of progressive SIV infection.
To examine the impact of SIV infection on the metabolism in the gut in vivo,
metabolomic analysis of intestinal samples from SIV-infected animals compared to
uninfected controls was performed. Data showed that several metabolic pathways were
downmodulated at 60 h of SIV infection compared to SIV-negative controls (Fig. 1A).
Changes in protein synthesis and amino acid metabolism processes were particularly
notable, as multiple amino acids (phenylalanine, tyrosine, and aspartate and, to a lesser
extent, cysteine, glycine, serine, threonine, arginine, proline, histidine, beta-alanine,
lysine, tryptophan, methionine, valine, leucine, and isoleucine) and their metabolism
were inhibited. However, downmodulation of protein synthesis and amino acid me-
tabolism was less pronounced while starch and sucrose metabolism was significantly
TABLE 1 Animals for metabolic analysisa
Animal ID SIV status
Wk
postinfection
Viral load
(SIV copies/ml plasma)
Gut viral load
(SIV copies/g RNA)
Gut CD3 CD4
T cells (%)
39114 Negative 0 NA NA 54.3
37301 Negative 0 NA NA 51.6
37467 Negative 0 NA NA 70.4
39343 Negative 0 NA NA 61
35875 Positive 2.5 1,106 114 53.8
36429 Positive 2.5 301 301 53.6
36097 Positive 2.5 263 86 56.6
39296 Positive 10 79,738 566,710 1.0
36701 Positive 10 49,036 18,865 0.2
36719 Positive 10 23,291 13,513 25.9
39238 Positive 10 242,970 11,526 6.4
aAbbreviations: ID, identifier; NA, not applicable.
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downregulated during chronic SIV infection (Fig. 1B). Our findings suggest that down-
modulation of protein synthesis and amino acid metabolism occurred early in SIV
infection.
Rapid induction of ATF4 gene expression in vivo during early SIV infection but
not during chronic SIV infection. Metabolic dysfunction and amino acid deficiency
are reported in HIV-infected patients and in SIV-infected nonhuman primates (13–15).
The amino acid deficiency sensor GCN2-ATF4 signaling directs modulation of transcrip-
tion control and protein synthesis (12). To determine the role of ATF4 signaling during
early SIV infection in vivo, we examined changes in the expression of ATF4 and the
associated gene network in the gut mucosa during primary acute (2 weeks postinfec-
tion) and chronic (26 weeks postinfection) stages of SIV infection. We utilized gut
mucosal gene expression data using DNA microarray analysis from our previously
reported studies and mined the data to investigate changes associated with ATF4
signaling (17). This analysis showed that the expression of ATF4 as well as the genes
downstream of the GCN2-ATF4 signaling was increased in SIV-infected animals com-
pared to uninfected controls (Fig. 2A) (18). For the validation of the DNA microarray-
based gene expression data, we performed real-time PCR analysis using rhesus ma-
caque gene-specific primers and determined the expression levels of GCN2, eIF2, and
ATF4 genes in the gut tissues of SIV-infected animals and negative controls. It was
important to note that ATF4 expression in the gut mucosa was significantly increased
during acute SIV infection (1 to 2 weeks postinfection) but not during chronic SIV
infection (27 to 28 weeks postinfection) (Table 2) (Fig. 2B). The transcript levels of GCN2
or eIF2 were not significantly altered. The changes might have occurred at the level
of protein synthesis or posttranslational modification. To further examine the changes
in ATF4 expression in response to early viral infection, we expanded our analysis to in
vitro primary human CD4 T cells following HIV infection and measured the induction
of ATF4 expression. A productive HIV infection of CD4 T cells was established (Fig. 3A).
FIG 1 Metabolic changes and amino acid deficiency in the gut during early SIV infection. Top metabolic pathways downregulated in the gut of rhesus
macaques after 60 h (A) and at 10 weeks (B) post-SIV infection. ***, P  0.001; **, P  0.01; *, P  0.05 compared with samples from uninfected animals.
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These cells showed induction of ATF4 RNA expression (Fig. 3B), indicating that HIV
infection resulted in upregulation of expression of the ATF4 gene. This is consistent
with our data from the SIV model showing an increased ATF4 expression in vivo
during early SIV infection (Fig. 2A). In summary, our data suggest that SIV infection
FIG 2 Gene expression of ATF4 is induced in the gut during early SIV infection. (A) ATF4 signaling was
activated in gut tissues of rhesus macaques during SIV infection, AAR, amino acid response. (B) Intestinal
tissues from acute or chronic SIV-infected rhesus monkeys were collected, RNA was extracted, and
expression of GCN2, eIF2, or ATF4 was determined by RT-qPCR. *, P  0.05.
TABLE 2 Animals for gene expression and qPCR analysisa
Animal ID SIV Wk postinfection Viral load (copies)/g RNA
33675 Negative 0 NA
33842 Negative 0 NA
34249 Negative 0 NA
33832 Negative 0 NA
25317 Positive 1 1,290
25462 Positive 1 107
24882 Positive 2 247,931
25363 Positive 2 934
25365 Positive 2 4,484,518
30085 Positive 26 24,322
34785 Positive 27 2,261
34686 Positive 27 125
34829 Positive 27 20,649
33804 Positive 27 35,686
31353 Positive 28 164,544
aAbbreviations: ID, identifier; NA, not applicable.
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results in host antiviral mechanisms of amino acid deficiency, which induces
expression of ATF4.
Nutrient deprivation induces activation of HIV LTR-driven transcription in
CD4 T cell culture model in vitro. To assess whether the antiviral host response of
nutrient deprivation and reduced protein biosynthesis has any beneficial effect on HIV
replication, we utilized an established in vitro HIV latency cell culture model, the J-Lat
A1 (J-Lat) cells, which contain one integrated copy of HIV LTR that controls expression
of the green fluorescent protein (GFP) reporter gene. The expression of GFP is induced
in these cells following the activation of HIV LTR. The J-Lat cells were serum starved and
analyzed for the expression of GFP by flow cytometry. Nutrient deprivation of J-Lat A1
cells activated transcription of HIV LTR-directed GFP (Fig. 3C). To examine whether
depletion of amino acids modulates HIV replication, primary human CD4 T cells from
healthy donors were isolated and experimentally infected with HIV. These cells were
incubated in the amino acid-deficient medium, and HIV p24 protein levels in culture
FIG 3 Nutrient deprivation in human CD4 T cells induces ATF4 expression and HIV LTR activation. (A and B) Isolated primary CD4
T cells from healthy HIV-negative donors (n  4) were infected with HIV for 5 days, HIV p24 levels in supernatants were measured by
ELISA (A), and cell-associated ATF4 RNA levels were determined by RT-qPCR (B). (C) To determine the effect of nutrient deprivation,
J-Lat A1 cells were cultured in medium without serum for 24 to 72 h, and HIV LTR-driven GFP expression was assessed by flow
cytometry. (D) Primary human CD4 T cells were infected with HIV in complete medium or in medium without amino acids, and HIV
p24 expression was determined by ELISA. (E) J-Lat A1 cells were cultured in low levels of serum (10% to 0.0625% of serum in medium)
for 48 h, and HIV LTR-driven GFP expression was measured by RT-qPCR. (F) The U1 cells were cultured in low levels of serum (10%
to 0.0625% of serum in medium) for 48 h. HIV RNA was measured using RT-qPCR. *, P 0.05; **, P 0.01. Experiments were performed
a minimum of three times.
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supernatants were determined. We found that deprivation of amino acids enhanced
HIV replication in the primary CD4 T cells (Fig. 3D). This finding was further confirmed
by the detection of increased levels of GFP RNA levels in J-Lat A1 cells as measured by
quantitative PCR (qPCR) assays (Fig. 3E). In addition, the amino acid limitation in
chronically HIV-infected U1 (a subclone of the human U937 monocytic cell line that is
infected with HIV-1) cell cultures in vitro resulted in the induction of HIV transcription
(Fig. 3F). Our data showed that nutrient deprivation induces HIV transcription and viral
replication in both CD4 T cells and monocytes (Fig. 3E and F).
Nutrient deprivation induces ATF4 transcription in T cells and monocytes in
vitro. We sought to examine whether induction of HIV transcription following amino
acid deprivation involves changes in the ATF4 expression. We found that ATF4 mRNA
expression was induced under nutrient deprivation conditions in both J-Lat cells and
U1 cells (Fig. 4A). This is in accordance with our findings of the induction of ATF4 during
early SIV infection in vivo and in induction of HIV expression ex vivo (Fig. 2). It has been
previously reported that overexpression of ATF4 can activate HIV expression in CD4 T
FIG 4 Nutrient deficiency induces ATF4 expression in immune cells. (A) ATF4 expression was induced after nutrient
deprivation in both J-Lat A1 cells and U1 cells. J-Lat A1 cells or U1 cells were nutrient deprived for 48 h, and ATF4
expression was evaluated by RT-qPCR. *, P 0.05; **, P 0.01. (B and C) The J-Lat A1 cells (B) and U1 cells (C) were nutrient
deprived in medium with low levels of serum (10% to 0.0625%) for 48 h, and HDAC1 to HDAC4 gene expression was
evaluated by RT-qPCR. Experiments were performed a minimum of three times.
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cells (19). The GCN2-ATF4 signaling is essential in sensing the amino acid deprivation.
In both J-Lat A1 and U1 cell culture models, expression of ATF4 was induced under a
nutrient-deprived condition. In summary, amino acid deprivation induced HIV expres-
sion, possibly through ATF4 signaling.
It was reported that amino acid starvation reactivated latent HIV expression in vitro,
through downregulation of histone deacetylase 4 (HDAC4) (20). We sought to examine
whether induction of HIV transcription following amino acid deprivation also involved
changes in the HDAC expression. We analyzed J-Lat A1 cells in the nutrient starvation
state for the expression of several HDACs, including HDAC1, HDAC2, HDAC3, and
HDAC4. Our data showed that there was no demonstrable suppression of HDAC
expression, including that of HDAC4. Instead, expression of most HDACs was induced
in J-Lat A1 cells under a serum-starved condition (Fig. 4B). Therefore, nutrient
deprivation-induced HIV transcription was not associated with downmodulation of
HDACs in J-Lat A1 cells. To determine whether HDAC levels are altered by nutrient
deprivation in monocytes, studies were performed in the U1 monocytic cell line that
harbors the latent HIV genome. In contrast to J-Lat A1 cells, expression of HDAC1,
HDAC2, and HDAC3 was dampened in U1 cells (Fig. 4C). However, HDAC4 expression
was not detectable, and this is in agreement with a previous report (20). Thus,
expression of HDACs differed between T cells and monocytes under nutrient limitation.
However, the role of HDAC4 in the induction of HIV expression during nutrient
limitation remains to be determined.
Increased HIV transcription through GCN2-ATF4 signaling during amino acid
deprivation. To investigate the role of nutrient deprivation-associated GCN2-ATF4
signaling for the induction of HIV transcription, the J-Lat A1 cells were treated with
GCN2-specific inhibitor during nutrient deprivation. We found that SP600125, a potent
GCN2 inhibitor, effectively suppressed nutrient deprivation-induced HIV transcription in
J-Lat A1 cells and HIV reactivation in U1 cells (Fig. 5A and B) (21). Supplementation of
the nutrient-deficient cultures of J-Lat A1 cells with amino acids (phenylalanine and
lysine) suppressed the activation of HIV transcription (Fig. 5A). However, amino acid
supplementation of the nutrient-deprived U1 cells was not effective in suppressing HIV
LTR-driven transcription (Fig. 5B). It is possible that HIV expression during nutrient
deprivation might engage mechanisms other than the GCN2-ATF4 signaling. Our data
suggest that GCN2-ATF4 signaling is involved in the amino acid deprivation-induced
HIV activation in immune cells.
Amino acid deprivation promotes ATF4 binding to HIV LTR. Amino acid depri-
vation regulates gene expression at multiple steps, including chromatin remodeling,
mRNA splicing, RNA export, and translation (22). During amino acid deprivation, a
few genes are expressed at higher levels, including that of ATF4. The ATF4 protein
can increase gene transcription by binding to the CCAAT-enhancer binding protein-
activating transcription factor response elements (C/EBP-ATF) in the target gene pro-
moter. Previously, two C/EBP-ATF binding sites (5= TGACGTAA 3=) were identified in HIV
LTR and confirmed using super-electrophoretic mobility shift assays (EMSAs) in vitro
(23). The nucleotide sequence analysis of the HIV LTR sequence using PROMO software
identified several transcriptional factor binding sites in HIV LTR, including those known
for enhancing HIV replication, such as NF-B, Sp1, NFAT, and YY1 (data not shown).
Importantly, we identified several additional potential C/EBP-ATF binding sites in HIV
LTR and one C/EBP-ATF binding site in SIV LTR (Fig. 6A). If ATF4 is essential for induction
of HIV transcription during amino acid deprivation, ATF4 should be recruited to the HIV
promoter to facilitate the viral transcription. To test this hypothesis, chromatin immu-
noprecipitation (ChIP) assays were performed using anti-ATF4 antibodies following
cross-linking of HIV-infected cells in the presence or absence of amino acid deprivation.
The PCR primers were targeted to the LTR region of the HIV promoter (116 bp to
4 bp) (24). Our data show that amino acid deprivation induced significant levels of
ATF4 binding to the HIV LTR compared to control cells maintained with amino acid
supplementation (Fig. 6B). Our findings support the model in which amino acid
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deprivation induces ATF4 and increases ATF4 binding to C/EBP-ATF sites in the HIV LTR.
This leads to enhanced HIV transcription and replication.
Induction of ATF4 in T cells reactivates latent HIV. We sought to examine
whether ATF4 is directly linked to the induction of HIV expression in immune cells
during nutrient deprivation. The CD4 T cells (J-Lat A1) were treated with selenium. It
has been previously reported that selenium induces expression of ATF4 in the Jurkat
CD4 T cell line (25). Treatment of J-Lat cells with selenium induced reactivation of HIV
and expression of ATF4 (Fig. 7A and B). Similarly, selenium treatment of monocytic U1
cells also induced reactivation of latent HIV and expression of ATF4 (Fig. 7C and D). We
expanded this investigation to the primary CD4 T cells from HIV-infected patients
receiving long-term antiretroviral therapy (ART). Viral loads in peripheral blood of these
patients were below 20 copies/ml. Treatment of primary CD4 T cells with selenium
resulted in the induction of HIV expression in cells from 4 of 6 patients (Fig. 7E). In
conclusion, activation of ATF4 expression was linked to the induction of HIV expression.
Our findings suggest that ATF4 signaling may serve as a new target for limiting early
establishment of HIV infection and latency.
DISCUSSION
Viruses have evolved to overcome antiviral mechanisms employed by mammalian
hosts to prevent or eradicate viral infection. Retroviruses are known to mutate their
genomes to escape virus-specific host immune response. They also encode accessory
viral proteins that dampen the host immune system and/or modulate host cell targets
for enhancing viral replication. In recent times, viral strategies have been identified that
enable viruses to exploit host antiviral innate responses for establishing viral infection
and its persistence (26). Our findings demonstrate that HIV may exploit the host
FIG 5 Suppression of GCN2 or amino acid supplementation inhibits induction of HIV expression. J-Lat
A1 (A) or U1 (B) cells were nutrient deprived in medium with low levels of serum (0.125% of FBS in
medium) in the presence of 10 M GCN2 inhibitor (SP600125) or 1 mM amino acids (Phe/Lys) for 48 h,
and HIV expression was evaluated by qPCR. *, P  0.05; **, P  0.01, compared with 10% FBS medium
control; #, P  0.05; ##, P  0.01, compared with nutrient deprivation (0.125% [A] and 0.062% [B]).
Experiments were performed a minimum of three times.
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antiviral integrated stress response from the infected host for establishing early stages
of viral replication and dissemination.
Gut-associated lymphoid tissue plays an important role in maintaining persistence
of HIV reservoirs and chronic immune activation. Due to the frequent exposures to
pathogens and environmental stimuli, gut mucosa has evolved to be highly enriched
in innate defense mechanisms to control pathogens as well as to limit gut inflammation
(27). Effects of active HIV replication and viral antigens on the impairment of gut
immunity and epithelial barrier disruption are well recognized. However, our under-
standing is limited regarding the mechanisms by which HIV is able to initiate early
replication and viral production in an innate defense-enriched gut microenvironment
that is hostile to pathogens. Our findings of early suppression (at 60 h post-SIV
infection) of protein biosynthesis in the gut mucosa represent the initial host innate
response to the acute viral infection. By limiting the amino acid availability and protein
synthesis, the host antiviral innate response leads to the restriction of the viral pro-
duction. This innate defense is effective since the retrovirus production is totally reliant
on the supply of amino acids and protein synthetic machinery from the host cell.
Therefore, the decrease in the protein synthesis during the initial stages of viral
infection is an effective strategy of the host innate sensing and response to the viral
infection. In contrast, decreased protein synthesis during chronic SIV infection may be
attributed to several mechanisms. At 10 weeks post-SIV infection and thereafter, viral
loads in the gut mucosa are accompanied by severe CD4 T cell depletion, increased
CD8 T cell prevalence, disruption of the gut epithelial barrier integrity, and inflam-
matory cytokines. Thus, nutritional complications and tissue dysfunction may also
contribute to changes in protein biosynthesis during chronic viral infection. Also, at this
time, inflammatory cytokines induce cell activation and prime the cellular targets for
viral infection and depletion in the gut mucosa. In addition, several other transcription
factors may also be readily available in the activated cells to support the viral infection.
Last, the viral protease is fully capable of degrading the GCN2 and destroying this
FIG 6 ATF4 is recruited to HIV LTR following amino acid deficiency. (A) Potential CREB/ATF binding sites identified in the HIV (top) and
SIV LTR (bottom) region using PROMO software. The underlined sequence is the potential ATF4 binding site in the viral LTR. (B) ATF4 is
recruited to HIV LTR after amino acid depletion. J-Lat cells were cultured in medium without amino acids (AA) for 18 h, and ChIP assays
were performed with anti-ATF4 antibodies and analyzed by SYBR-qPCR with PCR primers targeting HIV LTR. Fold change of ATF4 binding
to HIV LTR was calculated after being normalized to control treatment. *, P  0.05. Experiments were performed three times.
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innate host defense. HIV protease was previously shown to cleave GCN2 in the cell
culture models (28).
Amino acid deficiency and inhibition of protein biosynthesis have been well re-
ported in HIV-infected adults and children or in SIV-infected rhesus macaques (13, 14,
FIG 7 Induction of ATF4 expression by selenium reactivates latent HIV. (A) J-Lat cells were treated with 4 to 16 M
selenium for 24 h, and GFP expression was assessed using flow cytometry to determine latent HIV LTR reactivation. **, P 
0.01. (B) J-Lat cells were treated with 4 to 16 M selenium for 24 h, and ATF4 gene expression was determined by RT-qPCR.
*, P  0.05. (C) U1 cells were treated with 2.5 to 15 M selenium for 24 h, and viral expression was assessed by RT-qPCR
to determine latent HIV reactivation. **, P  0.01. (D) The U1 cells were treated with 2.5 to 15 M selenium for 24 h, and
ATF4 gene expression was determined by RT-qPCR. *, P  0.05. (E) Isolated primary CD4 T cells from HIV-infected
individuals on suppressive ART were treated with DMSO, 200 ng/ml PMA plus 2 M ionomycin, or 16 M selenium for 6 h.
Induction of HIV transcription was measured by RT-qPCR for the 5= LTR region of the virus. (F) The proposed model for the
GCN2-eIF2 signaling in early HIV replication. HIV/SIV infection induces antiviral host innate defense to restrict viral
production by reducing amino acid deficiency and shutting down protein synthesis. This triggers GCN2-eIF2 signaling
and induces ATF4 expression. The virus hijacks this mechanism to recruit ATF4 to the viral LTR and enhance viral
replication. During the advanced HIV infection, GCN2 is degraded by HIV protease, the level of ATF4 decreases, and its
impact is diminished. Thus, ATF4 may be critical in the initial stages of HIV replication. Data from panels A to D were from
three independent experiments.
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29, 30). Many of these changes are reversed during highly active ART (HAART) (31).
Inhibition of host cellular protein synthetic activity is driven by the activation of
GCN2-eIF2 signaling, which induces expression of ATF4. We found that both metab-
olism of amino acids and protein biosynthesis were decreased in the gut mucosa
during early SIV infection at a higher magnitude than in chronic SIV infection. A
substantial increase in ATF4 expression was detected during acute SIV infection in vivo
using quantitative reverse transcription polymerase chain reaction (RT-qPCR). We did
not detect significant increases in the mRNA levels of GCN2 and eIF2 in the gut
mucosa during early SIV infection. This is not surprising since the activation of GCN2
and eIF2 occurs at the posttranslational level through modification by phosphoryla-
tion. Analysis of human CD4 T cell cultures and promonocytic cells under an exper-
imental nutrient deprivation condition showed a significant increase in ATF4 expression
that correlated with the transcriptional activation of HIV LTR. These data are in
agreement with our findings from the SIV model in vivo (Fig. 2). Increased levels of ATF4
during early stages of viral infection can have a direct impact on establishing early viral
reservoirs due to its ability to induce viral transcription. However, HIV expression was
suppressed in the presence of GCN2 kinase inhibitor or by supplementation of amino
acids. Our findings reveal a novel mechanism evolved by HIV to exploit the host
antiviral restrictive response for establishing its infection. Several previously published
reports support our hypothesis. The amino acid deficiency and decreased protein
synthesis have been previously reported in HIV, SIV, and several other viral infections
(14, 30). Transfection of the ATF4 gene in a T cell line induced HIV LTR transactivation
even in the absence of Tat (19). We examined the ATF4 binding site in the LTR in the
context of other known transcription factor binding sites, specifically NF-B, Sp1, and
NFAT. They do not seem to overlap the ATF4 binding site, as their consensus binding
sequences are quite different. Further, except for ATF4, these well-known HIV tran-
scriptional factors are not among the proteins that were induced by GCN2-ATF4
signaling. Taken together, our data indicated that amino acid deficiency and inhibition
of protein biosynthesis as well as the induction of GCN2-ATF4 signaling mainly occur
during acute HIV/SIV infection. However, further investigation is warranted regarding
GCN2-ATF4 signaling and its role in HIV/SIV replication during chronic infection.
Epigenetic silencing of HIV is induced by histone deacetylase (HDAC) enzymes
through chromatin remodeling and supports the maintenance of latent viral reservoirs.
Therefore, HDAC inhibitors have been used to reactivate HIV from latency. It has been
reported that amino acid starvation and targeted HDAC4 inhibition resulted in reacti-
vation of latent HIV in a T cell line but not in a promonocytic U1 cell line that lacks
HDAC4 (20). We examined HDAC expression and HIV transcription in CD4 T cell
cultures and promonocytic U1 cells under conditions of nutrient deprivation. Our data
showed that the expression of HDAC1 to HDAC4 was induced and not suppressed in
the CD4 T cell cultures. Surprisingly, expression of HDAC1 and HDAC2, and to a lesser
extent of HDAC3, was increased in the monocytic cell cultures. However, HDAC4
expression was too low for detection in U1 cells and was not altered under the nutrient
deprivation conditions, as previously reported (20). It seems that HDACs may exert a
differential effect on transcription of HIV in lymphoid and myeloid cells during the
amino acid deprivation.
Previously, ATF was reported to have a potential effect on HIV replication (19).
Several potential ATF/CREB binding sites were identified in the HIV LTR region using
EMSAs in vitro (23, 32). Another study reported that DNA methylation of these ATF/
CREB sites was involved in establishing HIV latency (33). ATF4 was recently shown to
activate HIV replication in vitro by transactivating HIV LTR with as well as without Tat
(19). However, the relevance of ATF4 expression during early HIV infection is not
defined. In the present study, we found that activation of GCN2-ATF4 was caused by
amino acid deprivation, which facilitates ATF4 binding to the HIV LTR to drive HIV
transcription/replication. Consequently, inhibition of GCN2 or supplementation of
amino acids during the serum starvation suppressed reactivation of latent HIV. Al-
though 4-phenylbutyrate is an effective GCN2-eIF2-ATF4 signaling inhibitor, it is also
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a pan-HDAC inhibitor and is known to reactivate latent HIV (34, 35). Therefore, we did
not include 4-phenylbutyrate in our assays since the application of 4-phenylbutyrate
might complicate our analysis of latent HIV reactivation.
It is interesting that ATF4 expression may have a defining role in establishing early
stages of HIV/SIV infection. It may also be utilized for activating latent HIV reservoirs.
Epigenetic modification of ATF/CREB binding sites appeared to be essential for HIV
reactivation from latency (33). Induction of ATF4 expression led to reactivation of latent
HIV in vitro and ex vivo, suggesting the role of ATF4 in maintaining HIV latency. In
agreement with previously reported findings (19), addition of selenium to CD4 T cells
and monocytic cells induced expression of ATF4. We found that selenium, as an inducer
of the ATF4 expression, also reactivated expression of latent HIV in both J-Lat A1 cells
and U1 cells, as well as in primary CD4 T cells from HIV patients under suppressive
ART. The association of selenium with increased HIV viral loads in AIDS patients was
reported in several clinical trials. In a randomized trial, micronutrients plus selenium
supplementation resulted in higher levels of genital HIV-1 shedding than those with
placebo in ART-naive AIDS patients (36). The effect was lost when the same micronu-
trients were administered without selenium at identical dosages in patients. Instead,
administration of micronutrients lacking in selenium resulted in lower levels of HIV RNA
viral loads (37). To investigate the effect of selenium on HIV viral loads, a clinical study
was performed in 340 HIV-infected pregnant women, which demonstrated that the
presence of high levels of selenium resulted in increased risk of genital HIV-1 shedding
(38). A recent study showed that selenium supplementation among some of the
therapy-naive HIV-infected women led them to show higher levels of viral RNA in their
breast milk (39). These findings indicate the role of selenium in supporting HIV
expression in vivo. We found that selenium could reactivate latent HIV in primary CD4
T cells from some HIV-infected individuals receiving suppressive HAART ex vivo. It
appears that selenium induced HIV replication before ATF4 expression in CD4 T cells
(Fig. 7A and B), indicating that selenium induction of HIV replication may involve
additional signaling pathways. Although the effect of selenium in reactivation of latent
HIV was modest, it further supported the role of ATF4 in viral activation. In addition, our
findings may provide an explanation for increased susceptibility to HIV infection among
children and adults suffering from malnutrition in developing countries (40, 41).
Induction of the GCN2-ATF4 pathway under the conditions of amino acid starvation
may support HIV transcription and spread in these individuals. The role of stress in
reactivation of HIV reactivation is underinvestigated (42). Our data indicated that
nutrient stress-induced GCN2-ATF4 signaling can be targeted for reactivating latent HIV
during HAART.
In summary, our data show that early stages of SIV infection induce inhibition of
protein synthesis and amino acid depletion in the gut mucosa, potentially an early
antiviral host response, through GCN2-ATF4 signaling. Increased expression of ATF4
during this early stage of SIV infection has a direct impact on the viral transcription as
a viral LTR transactivator. Our findings suggest a model that the antiviral host response
to HIV/SIV infection through GCN2-ATF4 signaling may be exploited by the virus to
activate its transcription and expression, may be highly relevant during the early stages
of infection in vivo, and may serve as an excellent target for prevention of viral
dissemination.
MATERIALS AND METHODS
Human cell cultures. J-Lat A1 (J-Lat) cells or U1 cells were obtained from the NIH AIDS Reagent
Program and cultured in RPMI 1640 medium with 10% fetal bovine serum (FBS) and 1% penicillin-
streptomycin (Pen-Strep) in a 37°C incubator containing 5% CO2 (43, 44). The reactivation of HIV LTR was
quantified by GFP expression using flow cytometry. The data were analyzed using FlowJo Software for
J-Lat cells or by RT-qPCR for both J-Lat and U1 cells.
Metabolic analysis. An untargeted primary metabolic analysis of macaque gut tissue was performed
by gas chromatography-time of flight (GC-TOF) mass spectrometry (MS). Ten to 20 mg of cryopreserved
gut tissue was obtained from SIV-infected animals during the early stage at 60 h postinfection (n  3)
or during chronic stage at 10 weeks postinfection (n  4) and from SIV-negative controls (n  4). Tissue
samples were homogenized in an extraction mixture of acetonitrile, isopropanol, and water (3:3:2) and
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centrifuged, and supernatants were evaporated. Dried pellets were dissolved in 50% acetonitrile,
evaporated, and subjected to a two-step derivatization using methoximation and trimethylsilylation. The
GC-MS analysis was performed using an Agilent 7890 gas chromatography system coupled to an Agilent
5977A mass spectrometer by the West Coast Metabolomics Center at UC Davis, as previously described
(45). Overrepresentation analysis (ORA) was performed in Metabolites Set Enrichment Analysis (MSEA)
software (http://www.metaboanalyst.ca) using the metabolic pathways library from MSEA for all metab-
olites showing a 1.3-fold change.
Serum or amino acid starvation/adding assays. After being washed twice with phosphate-
buffered saline (PBS), 1  106 J-Lat A1 cells or U1 cells were cultured in a 12-well plate in RPMI (US
Biological, Salem, MA) with serum (Invitrogen), without serum, or without amino acids for 24 h to 72 h.
Cells were collected for either flow cytometry or RNA extraction. Also, 10 M GCN2 kinase inhibitor
SP600125 or 1 mM amino acid was added to the J-Lat A1 or U1 cell cultures at low levels of serum.
Primary CD4 T cell isolation and treatments. Peripheral blood samples were collected from
healthy donors (n 4) or from HIV-infected individuals receiving suppressive antiretroviral therapy (ART)
for 3 years (n  6). The CD4 T cell counts in peripheral blood samples ranged from 264 to
1,100 cells/mm3, and plasma viral loads were20 copies per ml as measured by qPCR. CD4 T cells were
isolated using the EasySep kit (StemCell Technologies Inc., Vancouver, BC, Canada) as previously
described (44, 46). The purified CD4 T cells were plated at a density of 1  106 cells and treated with
dimethyl sulfoxide (DMSO), 200 ng/ml phorbol myristate acetate (PMA) plus 2 M ionomycin, or 16 M
selenium for 6 h, and the cell pellets were collected for RNA isolation.
Rhesus macaques and viral infections. Rhesus macaques (Macaca mulatta) were obtained from the
California National Primate Research Center (CNPRC). Peripheral blood and intestinal tissue samples were
obtained from 21 rhesus macaques (age ranging from 4 to 6 years). Fifteen animals were intravenously
infected with 1,000 50% tissue culture infective doses (TCID50) of SIVmac251 and necropsied at either
60 h (n  3), 2 weeks (n  5), 10 weeks (n  4), or 26 weeks (n  3) following SIV infection. Six healthy
SIV-negative rhesus macaques served as negative controls. Immunological and virological findings from
some of these animals were previously described (17, 18). At 60 h post-SIV infection, there is a low level
of viral infection in the gut and peripheral blood, prior to any detectable loss of CD4 T cells due to
infection, while at 1 to 2 weeks post-SIV infection, there is a wider dissemination of viral infection to the
susceptible cellular targets that is accompanied by the loss of mucosal CD4 T cells. At 8 weeks onward
following SIV infection, the viral loads in the peripheral blood reach a steady state. Therefore, time points
thereafter represent the chronic stage of viral infection, which includes both 10- and 26-week infection
time points in our study. Severe CD4 T cell depletion and viral persistence are detected in the gut
mucosa in the chronic SIV infection.
Rhesus macaque gene expression by DNA microarray analysis and real-time PCR. RNA was
isolated from gut tissue samples using the RNeasy kit (Qiagen, Valencia, CA). mRNA amplification,
labeling, hybridization to GeneChips (Affymetrix), staining, scanning, and statistical analysis of the data
were performed as described previously (18). Fluorescence intensity values from scanned GeneChips
were subjected to comparative analyses utilizing R statistical software and BRB Array Tools and Ingenuity
Pathway Analysis (IPA) software as previously described (18). The previously analyzed data files were
mined for the expression of GCN2-ATF4 signaling-related genes.
For the validation of the DNA microarray-based gene expression data, rhesus macaque-specific
primers/probes for GCN2, eIF2, and ATF4 genes were obtained and real-time PCR was performed to
quantitate RNA levels of these genes in the gut tissue samples of SIV-infected animals and negative
controls.
ChIP. The chromatin immunoprecipitation (ChIP) assay was performed as previously described (44,
46, 47). Briefly, J-Lat A1 cells were fixed in 1% formaldehyde and suspended in lysis buffer containing 1%
SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1 (ChIP assay kit; Millipore), and a protease inhibitor cocktail
(Sigma-Aldrich). Lysates were sonicated to obtain DNA fragments of 200 to 1,500 bp. After incubation
with anti-ATF4 antibodies (ABE387; EMD-Millipore) overnight, the immune complex was retrieved by
incubating lysates for 45 min with 50 l of protein A/G agarose beads saturated with bovine serum
albumin (BSA)-salmon sperm DNA. Following the washes, the chromatin was eluted and reverse
cross-linked overnight. DNA was extracted (Qiagen PCR purification kit), and quantitative real-time PCR
was performed using Agilent Brilliant Ultra-Fast SYBR green QPCR reagent and the 7500 real-time PCR
system. The upstream primer sequence was 5= AGCTTGCTACAAGGGACTTTCC 3=, and the downstream
primer sequence was 5= ACCCAGTACAGGCAAAAAGCAG 3=. These PCR primers targeted the HIV LTR
region (116 bp to 4 bp).
HIV gene expression by real-time PCR analysis. Total RNA was isolated using the RNeasy kit
(Qiagen) followed by digestion with DNase I (Invitrogen). First-strand cDNA was synthesized using
Superscript III (Invitrogen). Real-time PCR (TaqMan) was performed on a ViiA7 detector using a primer/
probe set as previously reported (44, 46). The glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
primer/probe set was purchased from Applied Biosystems and used for control PCR.
HIV infection of primary CD4 T cells. Primary CD4 T cells were isolated from peripheral blood
samples of healthy HIV-negative donors (n  4) and infected with HIV-1 (HIV-1 IIIB expanded in Jurkat
T cells, 100 to 200 ng p24-gag) by spinoculation as described previously (48). Following an exposure to
HIV for 24 h, cells were washed with PBS, cell supernatants were collected after 3 to 5 days, and HIV p24
levels were measured by enzyme-linked immunosorbent assay (ELISA). The cells were also collected for
RNA extraction and viral RNA measurements by RT-qPCR.
HIV RNA quantification in patient samples. Total RNA was extracted with the Qiagen RNeasy kit,
including a DNA digestion step. Quantitative RT-PCR was performed using TaqMan Fast Virus 1-Step
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master mix (Applied Biosystems) in a ViiA7 thermocycler. Transcripts containing the 3= poly(A) region
were amplified as previously reported (44).
Ethics statement. This study was carried out under the recommendations of the Public Health
Services Policy on Humane Care and Use of Laboratory Animals. Animals were housed at the California
National Primate Research Center, and procedures were performed according to a protocol approved by
the Institutional Animal Care and Use Committee of the University of California, Davis. Appropriate
sedatives, anesthetics, and analgesics were used during handling and surgical manipulations to ensure
minimal pain, suffering, and distress to animals. Animals were euthanized in accordance with the
American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals. Human
samples were obtained under informed written consent and a protocol approved by the UC Davis
Institutional Review Board (IRB 219139).
Statistical analysis. Means and standard errors (SEs) were calculated for all data points from at least
3 independent experiments. Statistical significance was determined using the two-way Student t test,
where a P value of 0.05 was considered significant.
Data availability. The original microarray data analysis was previously reported (18).
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